Yael Glassman

Yael Glassman is a prominent business leader currently serving as the Vice President of Business Development and Strategy for Diabetes at Medtronic. In this role, she is responsible for leading her team in developing innovative solutions to enhance diabetes management through Medtronic's product offerings.

Education and Career Background

Glassman holds a Bachelor of Arts in Psychology and Communications from the Hebrew University of Jerusalem and an MBA from the MIT Sloan School of Management. Before joining Medtronic, she was the CEO and President of Nutrino Health, where she played a key role in driving the company's global growth until its acquisition by Medtronic in 2019. Her extensive experience also includes senior positions in business development and marketing at various healthcare organizations, such as Sensible Medical Innovations, American Well, and The TriZetto Group.1

Contributions and Expertise

At Medtronic, Glassman focuses on strategic investments and acquisitions, particularly in the digital health sector. Her background in both corporate leadership and entrepreneurship equips her with unique insights into the dynamics of mergers and acquisitions in the healthcare industry. She has been involved in discussions about the strategic considerations companies like Medtronic take into account when acquiring startups, emphasizing the importance of addressing significant health challenges through innovative solutions.12